Same Brand, Different Bottle: What Illinois Just Admitted About US Skincare

On 19 August 2026, Illinois signed House Bill 3409, the Chemicals in Cosmetic Products Act. From July 2028, it will ban a list of ingredients from cosmetics sold in the state — ingredients that have already been illegal in the EU and UK for years, in some cases decades. Illinois is the first US state to do this. That fact alone tells you something most shoppers don’t know: the same global brand can legally sell a materially different formula depending on which country’s shelf it’s sitting on, and almost nobody buying the product realises it.

This isn’t a story about one bad ingredient sneaking through. It’s a story about two entirely different regulatory philosophies producing two different products under one label.

The Gap in Numbers

The EU Cosmetics Regulation (EC 1223/2009) works from a banned-until-proven-safe list. It currently restricts or prohibits more than 1,300 substances from cosmetic use, and the list is added to regularly as new safety data emerges.

The US federal system works the other way round. The FDA does not pre-approve cosmetic ingredients before they go on sale. A brand can put almost anything into a product, sell it, and only face action after the fact if the FDA can demonstrate harm — a slow, resource-heavy process. The result: roughly a dozen ingredients are federally restricted in US cosmetics. Formaldehyde-releasing preservatives, certain phthalates and specific colour additives that the EU banned years ago have remained legal for use in American formulations because nobody has been required to prove otherwise before they hit shelves.

That gap — 1,300-plus versus roughly 11 — is not a rounding difference. It’s two different regulatory universes, and multinational cosmetics companies formulate to whichever one applies in the market they’re selling into.

Why the Same Name Doesn’t Mean the Same Formula

Here’s the part that catches people out: brands don’t announce this. There’s no label that says “EU formula” or “US formula.” The packaging looks the same, the marketing copy is often identical, and the price tag gives no clues either way.

It happens because of how large cosmetics companies actually operate. A conglomerate selling a moisturiser under one brand name across dozens of countries doesn’t run one global formula through one global regulatory system — it runs regional formulations through whichever regulatory bar applies locally, the same structural logic explored in the parent company problem: a handful of corporations own most of the brands on the shelf, and those corporations optimise for compliance and cost market by market, not brand by brand. A preservative or fragrance component that’s cheap and effective but restricted in the EU can simply stay in the US version of a formula, because nothing in US law requires it to be reformulated. The EU version swaps it for a pricier, EU-legal alternative. Both bottles carry the same brand name. Only one of them had to clear the higher bar.

This is a different mechanism from the one behind professional versus retail product lines, where the same formula is sold at different prices through different channels. Here, the formula itself genuinely changes — not for marketing reasons, but because two governments disagree, sometimes by a factor of over 100, on what counts as an acceptable ingredient.

”Tested” and “Safe” Mean Less in the US Than the Label Implies

Ask most American shoppers whether their skincare is “tested” and they’ll say yes, of course — there’s an FDA, isn’t there. But FDA oversight of cosmetics is fundamentally reactive. Unlike drugs, cosmetic products and their ingredients are not required to undergo FDA review or approval before going to market. Companies are legally responsible for the safety of their own products, and they largely self-police through industry safety panels rather than an independent regulator checking their work in advance.

The EU inverts this. A cosmetic ingredient has to pass a formal safety assessment by the Scientific Committee on Consumer Safety before it can be used at all, and that assessment gets revisited as new toxicology data appears — which is exactly the mechanism that’s already flagged the ingredients Illinois is now legislating against. The EWG’s Skin Deep database, for all its own limitations as a hazard-versus-risk tool, has flagged this exact asymmetry for years: it’s a US-based database that primarily references US regulatory status, and US regulatory status is a lower bar than EU status on a long list of ingredients.

None of this means American-formulated products are dangerous at typical use levels — for most ingredients on the divergence list, the actual health risk from normal cosmetic exposure is modest, which is part of why the FDA hasn’t prioritised acting on them. But “modest risk, unregulated” and “tested safe” are not the same claim, and the marketing language rarely distinguishes between them.

What This Means If You Shop Across Borders

If you buy skincare while travelling, through international retailers, or via brands that ship the same SKU to multiple countries, you cannot assume the ingredient list is identical to the one you’d get buying locally. Check it. INCI ingredient lists are required on packaging in both markets, and they’re the only reliable way to know which formula you actually have in your hand — brand names, marketing copy and even product photography will tell you nothing.

Illinois passing HB 3409 is a genuinely significant regulatory moment: it’s the first crack in the assumption that US cosmetics regulation will simply stay where it’s been since 1938. But one state, effective in 2028, covering a limited ingredient list, does not close a gap of over a thousand substances. Until federal reform happens — and federal cosmetics law hasn’t been substantially rewritten in decades — the EU/US formulation gap remains the default, not the exception.

The Bottom Line

The myth here isn’t that any particular ingredient is secretly dangerous. It’s the assumption, held by almost every shopper, that a global brand sells one product worldwide and that wherever you’re buying, someone has already checked it’s fine. Neither is true. The EU and the US run genuinely different safety bars, global brands formulate to whichever bar applies locally, and the label gives you no way to tell which version you’re holding unless you read the ingredient list yourself and know what you’re looking for. Illinois just legislated an admission of that gap. It didn’t close it.